Literature DB >> 21987722

IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.

Thomas G Sommermann1, Kathleen O'Neill, David R Plas, Ellen Cahir-McFarland.   

Abstract

All cancer cells require increased nutrient uptake to support proliferation. In this study, we investigated the signals that govern glucose uptake in B-cell lymphomas and determined that the inhibitor of NF-κB-kinase β (IKKβ) induced glucose transporter-1 (GLUT1) membrane trafficking in both viral and spontaneous B-cell lymphomas. IKKβ induced AKT activity, whereas IKKβ-driven NF-κB transcription was required for GLUT1 surface localization downstream of AKT. Activated NF-κB promoted AKT-mediated phosphorylation of the GLUT1 regulator, AKT substrate of 160kD (AS160), but was not required for AKT phosphorylation of the mTOR regulator Tuberous Sclerosis 2 (TSC2). In Epstein-Barr virus-transformed B cells, NF-κB inhibition repressed glucose uptake and induced caspase-independent cell death associated with autophagy. After NF-κB inhibition, an alternate carbon source ameliorated both autophagy and cell death, whereas autophagy inhibitors specifically accelerated cell death. Taken together, the results indicate that NF-κB signaling establishes a metabolic program supporting proliferation and apoptosis resistance by driving glucose import.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987722      PMCID: PMC3228879          DOI: 10.1158/0008-5472.CAN-11-1715

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

Authors:  Casper Paludan; Dorothee Schmid; Markus Landthaler; Martina Vockerodt; Dieter Kube; Thomas Tuschl; Christian Münz
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

Review 2.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 3.  Good cop, bad cop: the different faces of NF-kappaB.

Authors:  N D Perkins; T D Gilmore
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

4.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.

Authors:  M A Lomaga; W C Yeh; I Sarosi; G S Duncan; C Furlonger; A Ho; S Morony; C Capparelli; G Van; S Kaufman; A van der Heiden; A Itie; A Wakeham; W Khoo; T Sasaki; Z Cao; J M Penninger; C J Paige; D L Lacey; C R Dunstan; W J Boyle; D V Goeddel; T W Mak
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

5.  Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.

Authors:  Roger G O'Neil; Ling Wu; Nizar Mullani
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

6.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

7.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

Authors:  J A Romashkova; S S Makarov
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

8.  RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.

Authors:  A T Ting; F X Pimentel-Muiños; B Seed
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

9.  Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT.

Authors:  E Zelzer; Y Levy; C Kahana; B Z Shilo; M Rubinstein; B Cohen
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.

Authors:  Alejandro Godoy; Viviana Ulloa; Federico Rodríguez; Karin Reinicke; Alejandro J Yañez; María de los Angeles García; Rodolfo A Medina; Mónica Carrasco; Sofía Barberis; Tamara Castro; Fernando Martínez; Ximena Koch; Juan Carlos Vera; María Teresa Poblete; Carlos D Figueroa; Bruno Peruzzo; Fernando Pérez; Francisco Nualart
Journal:  J Cell Physiol       Date:  2006-06       Impact factor: 6.384

View more
  53 in total

Review 1.  Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.

Authors:  Michael Lagunoff
Journal:  Curr Opin Virol       Date:  2016-07-18       Impact factor: 7.090

Review 2.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

3.  Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma.

Authors:  Chong Wang; Sizun Jiang; Liangru Ke; Luyao Zhang; Difei Li; Jun Liang; Yohei Narita; Isabella Hou; Chen-Hao Chen; Liangwei Wang; Qian Zhong; Yihong Ling; Xing Lv; Yanqun Xiang; Xiang Guo; Mingxiang Teng; Sai-Wah Tsao; Benjamin E Gewurz; Mu-Sheng Zeng; Bo Zhao
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

4.  Robust imaging and gene delivery to study human lymphoblastoid cell lines.

Authors:  Lachlan A Jolly; Ying Sun; Renée Carroll; Claire C Homan; Jozef Gecz
Journal:  J Hum Genet       Date:  2018-06-20       Impact factor: 3.172

5.  MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death.

Authors:  Amrita Datta Chaudhuri; Savan Kabaria; Doo Chul Choi; M Maral Mouradian; Eunsung Junn
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

Review 6.  Targeting glycogen metabolism in bladder cancer.

Authors:  Carolyn Ritterson Lew; Sunny Guin; Dan Theodorescu
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

7.  Autophagy prolongs survival after NFκB inhibition in B-cell lymphomas.

Authors:  Thomas G Sommermann; Hildegard I D Mack; Ellen Cahir-McFarland
Journal:  Autophagy       Date:  2012-02-01       Impact factor: 16.016

8.  Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.

Authors:  Ying-Ying Xu; Ting-Ting Wu; Shui-Hong Zhou; Yang-Yang Bao; Qin-Ying Wang; Jun Fan; Ya-Ping Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 9.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

10.  Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.

Authors:  Jun-Qiang Qian; Pei Sun; Zhan-Yu Pan; Zhi-Zhong Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.